Literature DB >> 12970318

Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.

Michael T Collins1, Nicholas J Sarlis, Maria J Merino, Jason Monroe, Susan E Crawford, Jonathan A Krakoff, Lori C Guthrie, Sandra Bonat, Pamela G Robey, Andrew Shenker.   

Abstract

McCune-Albright syndrome (MAS) is defined by the triad of café-au-lait skin pigmentation, polyostotic fibrous dysplasia, and hyperfunctioning endocrinopathies, such as precocious puberty, hyperthyroidism, GH excess, and Cushing's syndrome. This disorder is caused by sporadic, postzygotic activating mutations in the GNAS1 gene, which codes for the G(s)alpha protein in the cAMP signaling cascade. Nodular and diffuse goiters (with and without hyperthyroidism), as well as benign thyroid nodules, have been reported in association with MAS. Herein we report two cases of thyroid carcinoma in patients with MAS. The first is a case of papillary thyroid cancer detected incidentally during a hemithyroidectomy for hyperthyroidism in a 14-yr-old girl. The second is one of a 41-yr-old woman with long-standing MAS and an enlarging thyroid nodule, which was diagnosed as a clear cell thyroid carcinoma, a rare variant of thyroid cancer. Molecular analysis revealed that foci of malignancy and adjacent areas of hyperplasia and some areas of normal thyroid harbored activating mutations of Arg(201) in the GNAS1 gene. These findings suggest that the infrequent development of thyroid carcinoma in MAS patients involves additional mutational or epigenetic events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970318     DOI: 10.1210/jc.2002-021642

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  41 in total

1.  Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome.

Authors:  Kenshi Sakayama; Yoshifumi Sugawara; Teruki Kidani; Taketsugu Fujibuchi; Katsumi Kito; Nozomu Tanji; Atsushi Nakamura
Journal:  Int J Clin Oncol       Date:  2010-09-29       Impact factor: 3.402

2.  The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.

Authors:  Francesco S Celi; Giuseppe Coppotelli; Aaron Chidakel; Marilyn Kelly; Beth A Brillante; Thomas Shawker; Natasha Cherman; Penelope P Feuillan; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

Review 3.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

Review 4.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

5.  Detection of deregulated pathways to lymphatic metastasis in oral squamous cell carcinoma.

Authors:  Eryang Zhao; Jiankai Xu; Xiaodong Yin; Yu Sun; Jinna Shi; Xia Li
Journal:  Pathol Oncol Res       Date:  2008-09-18       Impact factor: 3.201

6.  Gastrointestinal polyps in McCune Albright syndrome.

Authors:  Margaret Zacharin; Anurag Bajpai; Chung Wo Chow; Anthony Catto-Smith; Constantine Stratakis; Michelle W Wong; Rodney Scott
Journal:  J Med Genet       Date:  2011-02-28       Impact factor: 6.318

7.  Analysis of GNAS mutations in cemento-ossifying fibromas and cemento-osseous dysplasias of the jaws.

Authors:  Milan M Patel; Jonathan F Wilkey; Rafik Abdelsayed; Nisha J D'Silva; Carl Malchoff; Sanjay M Mallya
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03-25

8.  GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.

Authors:  Marcus C Tan; Olca Basturk; A Rose Brannon; Umesh Bhanot; Sasinya N Scott; Nancy Bouvier; Jennifer LaFemina; William R Jarnagin; Michael F Berger; David Klimstra; Peter J Allen
Journal:  J Am Coll Surg       Date:  2015-02-11       Impact factor: 6.113

9.  GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".

Authors:  Hanno Matthaei; Jian Wu; Marco Dal Molin; Chanjuan Shi; Sven Perner; Glen Kristiansen; Philipp Lingohr; Jörg C Kalff; Christopher L Wolfgang; Kenneth W Kinzler; Bert Vogelstein; Anirban Maitra; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

Review 10.  DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.

Authors:  Luis F de Castro; Diana Ovejero; Alison M Boyce
Journal:  Eur J Endocrinol       Date:  2020-05       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.